Divis Laboratories Q4 Update: Profit At Rs 751 Crore, Revenue At Rs 2,831 Crore

$DIVISLAB will be in focus today, Monday, 25 May 2026, after reporting a steady Q4 performance on a consolidated YoY basis. The company posted a 13.4% rise in net profit at Rs 751 crore compared to Rs 662 crore last year, while revenue grew 9.5% to Rs 2,831 crore versus Rs 2,585 crore. The earnings reflect stable demand momentum and operational strength in the pharma manufacturing business. Investors will closely watch management commentary on margins, exports, demand outlook, and future growth visibility, which could drive stock movement in today’s trade. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.